Medtronic Receives FDA Approval For Neurostimulator


Medtronic’s RestorePRIME Neurostimulation System was approved yesterday March 24 by the FDA for the treatment of chronic pain. More specifically, it is indicated in patients with intractable pain of the trunk or limbs, and works by blocking pain by sending electrical pulses to the spine.

“The RestorePRIME System is a significant advancement in the field of neurostimulation,” said Joshua Prager, pain specialist and director of the Center for Rehabilitation of Pain Syndromes at University of California at Los Angeles School of Medicine.

The neurostimulator “allows physicians to customize the treatment to treat their patients’ chronic pain more accurately, potentially reducing the number of return visits and improving pain relief,” he said. [link]

The device is non-rechargeable and about the size of a stopwatch. Medtronic will begin launching it as soon as the end of March and into April, and it should be fully available by May. Patients can go to for more information on the RestorePRIME.


2 Responses to “Medtronic Receives FDA Approval For Neurostimulator”

  1. It’s genuinely very difficult in this full of activity life to listen news on TV, so I simply use world wide web for that purpose, and obtain the newest information.

  2. Attractive portion of content. I just stumbled upon your
    web site and in accession capital to assert that I get in fact loved account your blog posts.
    Anyway I will be subscribing on your augment and even I achievement you get
    entry to constantly rapidly.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: